CXCL10 and COVID-19: Expression of Cxcl10, a biomarker associated with severe COVID-19 outcomes (Gudowska-Sawczuk and Mroczko, 2022), was also significantly induced, with 20.4-fold and 6.2-fold increases at 3 and 6 dpi, respectively (Figure 2A).